Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × ruxolitinib × Clear all

NCT03774082 2025-12-11

REACH 5

Phase 2 Completed

46 enrolled 21 charts

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Lymphoma, Follicular